Search results
Results from the WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The two companies discussed a potential merger, uniting two of the largest pharmaceutical companies. This was eventually thwarted by Pfizer, in order to maintain control of the blockbuster drug - Lipitor. [20] [21] 8 2016 Bayer AG: Monsanto Company Inc. 65 83
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
With more than 130 clients that hail from the majority of the world’s top 20 pharmaceutical companies, that was a hefty task but also left more opportunities for human error, a major challenge ...
In this article we are going to list the 15 most valuable pharmaceutical companies in the world. Click to skip ahead and jump to the 5 most valuable pharmaceutical companies in the world. There is ...
The Access to Medicine Index ranks 20 of the world's largest originator (research-based) pharmaceutical companies, based on market capitalisation and the relevance of their product portfolios to diseases in the developing world. One unlisted company, Boehringer Ingelheim, is also included since it meets the size and portfolio relevance criteria.
Vifor Pharma AG (SWX:VIFN.SW) is a Swiss pharmaceutical company that develops treatments for iron deficiency, heart patients, and rare renal diseases. It is based in Sankt Gallen, Switzerland.